$KWR

QUAKER CHEMICAL CORP (KWR): Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

QUAKER CHEMICAL CORP (KWR) filed an SEC Form 8-K — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On October 16, 2026, Quaker Chemical Corporation (the “Company”) appointed Neil Daniels, age 61, as Vice President, Chief

Original reporting
Published Oct 22, 2026, 8:36 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 22, 2026, 8:39 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefCorporate actions
Primary signal
$KWR
Neutral
high confidence
Mentioned
$KWR
Relevance
6/10
AlphAI data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$KWRNeutralLow
01

Why it matters

The appointment does not introduce new business initiatives or financial guidance, so market reaction is expected to be muted.

02

Market read

Limited relevance; primarily of interest to current shareholders and analysts tracking management changes.

03

What to watch

Potential future impact of Daniels' experience at Teleflex, Nouryon, and Emergent BioSolutions on cost management.

Relevance 6/10Novelty 3/10Timing: effective November 16, 2026

Background

Quaker Chemical Corp (KWR) filed a Form 8‑K to disclose a senior accounting officer change, a routine corporate governance filing required by the SEC.

Company-level read

Ticker impact

$KWRNeutralHigh confidence
Context

Quaker Chemical Corp filed an 8‑K announcing the appointment of Neil Daniels as Vice President, Chief Accounting Officer with a $370k salary and $175k sign‑on bonus.

Expected impact

likely little movement as the change is routine and does not alter fundamentals.

Evidence & confidence

The filing is a standard corporate governance update; no new strategic direction or financial guidance is provided.

Market effects

None significant for the chemicals sector.

No regional effect.

Minimal; only relevant to Quaker Chemical shareholders.

Counterpoint

If investors view the new CFO as a catalyst for tighter financial control, a modest upside could emerge.

Key entities

  • Neil Daniels

    New Vice President, Chief Accounting Officer of Quaker Chemical Corp.

  • Thomas Coler

    Former principal accounting officer, now continues as EVP, CFO.

Related articles

$KWRMed

Quaker Chemical (KWR) Q2 2026 Earnings Call Transcript

Quaker Chemical (KWR) reported Q2 2026 net sales up 10% year over year, driven by mid- to high single-digit share gains, and adjusted EBITDA margins of 16%. The company cited double-digit volume growth in Asia Pacific, price actions, and $10 million run-rate cost savings. It authorized a $250 million buyback and raised its quarterly dividend about 4%. Outlook: end markets flat to modestly positive in 2H 2026; Q3 gross margin expected near Q2 and above 36% by year-end.

$KWRMed

Quaker Houghton Q2 Earnings Call Highlights

Quaker Houghton (NYSE:KWR) reported Q2 gross margin of 35.5%, down 130 bps sequentially, citing higher raw-material and container costs. GAAP diluted EPS was $1.55 and non-GAAP EPS $2.19. Asia-Pacific sales rose 12% YoY on 10% organic volume. Management expects Q3 gross margin roughly in line with Q2 and full-year adjusted EBITDA growth, while targeting >36% gross margin by year-end.

$KWRMedAI 8/10

QUAKER HOUGHTON ANNOUNCES SECOND QUARTER 2026 RESULTS

Q2'26 net sales of $532.6 million, an increase of 10% Y/Y Q2'26 net income of $26.8 million and earnings per diluted share of $1.55 Sales volumes increased 7% Y/Y primarily driven by new business wins across all segments Q2'26 non-GAAP net income of $37.9 million and non-GAAP earnings per diluted share of $2.19, a 28% increase Y/Y Delivered Q2'26 adjusted EBITDA of $85.2 million, a 13% increase Y/Y Increased quarterly dividend by approximately 4.3% and repurchased $24.2 million of shares...